AptarGroup, Inc.
US ˙ NYSE ˙ US0383361039

Introduction

This page provides a comprehensive analysis of the known insider trading history of Sarah JS Glickman. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Sarah JS Glickman has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CRTO / Criteo S.A. - Depositary Receipt (Common Stock) Chief Financial Officer 357,209
US:TSVT / 2seventy bio, Inc. Director 0
US:ATR / AptarGroup, Inc. Director 3,076
US:BLUE / bluebird bio, Inc. Director 0
US:XPO / XPO, Inc. Acting Chief Financial Officer 14,208
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Sarah JS Glickman. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ATR / AptarGroup, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ATR / AptarGroup, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ATR / AptarGroup, Inc. Insider Trades
Insider Sales ATR / AptarGroup, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ATR / AptarGroup, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ATR / AptarGroup, Inc. Insider Trades
Insider Purchases CRTO / Criteo S.A. - Depositary Receipt (Common Stock) - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ATR / AptarGroup, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CRTO / Criteo S.A. - Depositary Receipt (Common Stock) Insider Trades
Insider Sales CRTO / Criteo S.A. - Depositary Receipt (Common Stock) - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ATR / AptarGroup, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-08-25 CRTO Glickman Sarah JS 3,981 24.0600 3,981 24.0600 95,783 15 23.1300 -3,701 -3.86
2025-05-27 CRTO Glickman Sarah JS 1,520 26.1200 1,520 26.1200 39,702
2025-05-23 CRTO Glickman Sarah JS 2,465 25.8100 2,465 25.8100 63,622
2025-02-25 CRTO Glickman Sarah JS 17,883 40.3000 17,883 40.3000 720,685
2024-11-25 CRTO Glickman Sarah JS 1,520 40.3600 1,520 40.3600 61,347
2024-10-23 CRTO Glickman Sarah JS 5,442 40.6000 5,442 40.6000 220,945
2024-08-26 CRTO Glickman Sarah JS 1,519 49.1700 1,519 49.1700 74,689
2024-07-23 CRTO Glickman Sarah JS 5,496 45.4900 5,496 45.4900 250,013
2024-05-24 CRTO Glickman Sarah JS 1,535 38.9900 1,535 38.9900 59,850
2024-04-23 CRTO Glickman Sarah JS 5,504 35.3990 5,504 35.3990 194,836
2024-02-26 CRTO Glickman Sarah JS 9,653 32.6900 9,653 32.6900 315,557
2024-01-23 CRTO Glickman Sarah JS 3,622 24.7400 3,622 24.7400 89,608
2023-10-23 CRTO Glickman Sarah JS 2,752 28.1576 2,752 28.1576 77,490
2023-10-23 CRTO Glickman Sarah JS 2,752 28.1576 2,752 28.1576 77,490
2023-07-24 CRTO Glickman Sarah JS 2,710 32.6285 2,710 32.6285 88,423
2023-07-24 CRTO Glickman Sarah JS 2,751 32.6285 2,751 32.6285 89,761
2023-04-24 CRTO Glickman Sarah JS 2,521 30.2700 2,521 30.2700 76,311
2023-04-24 CRTO Glickman Sarah JS 2,521 30.2700 2,521 30.2700 76,311
2023-01-23 CRTO Glickman Sarah JS 2,827 28.9477 2,827 28.9477 81,835
2023-01-23 CRTO Glickman Sarah JS 2,827 28.9477 2,827 28.9477 81,835
2022-10-24 CRTO Glickman Sarah JS 25,510 26.0465 25,510 26.0465 664,446
2022-10-24 CRTO Glickman Sarah JS 28,224 26.0465 28,224 26.0465 735,136

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CRTO / Criteo S.A. - Depositary Receipt (Common Stock) Insider Trades
Insider Purchases XPO / XPO, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ATR / AptarGroup, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XPO / XPO, Inc. Insider Trades
Insider Sales XPO / XPO, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ATR / AptarGroup, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XPO / XPO, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Sarah JS Glickman as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-26 2025-08-25 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -3,981 357,209 -1.10 24.06 -95,783 8,594,449
2025-05-28 2025-05-27 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -1,520 361,190 -0.42 26.12 -39,702 9,434,283
2025-05-28 2025-05-23 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -2,465 362,710 -0.68 25.81 -63,622 9,361,545
2025-05-15 2025-05-13 4 TSVT 2seventy bio, Inc.
Common Stock
U - Other -15,602 0 -100.00
2025-05-15 2025-05-13 4 TSVT 2seventy bio, Inc.
Common Stock
D - Sale to Issuer -12,050 15,602 -43.58
2025-05-09 2025-05-07 4 ATR APTARGROUP, INC.
Common Stock
A - Award 1,069 3,076 53.26
2025-03-04 2025-02-28 4 CRTO Criteo S.A.
Ordinary Shares
A - Award 32,456 365,175 9.75
2025-03-04 2025-02-28 4 CRTO Criteo S.A.
Ordinary Shares
A - Award 38,724 332,719 13.17
2025-02-26 2025-02-25 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -17,883 293,995 -5.73 40.30 -720,685 11,847,998
2024-11-26 2024-11-25 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -1,520 311,878 -0.49 40.36 -61,347 12,587,396
2024-10-25 2024-10-23 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -5,442 313,398 -1.71 40.60 -220,945 12,723,959
2024-08-27 2024-08-26 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -1,519 318,682 -0.47 49.17 -74,689 15,669,594
2024-07-25 2024-07-23 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -5,496 320,201 -1.69 45.49 -250,013 14,565,943
2024-06-12 2024-06-10 4 TSVT 2seventy bio, Inc.
Common Stock
A - Award 12,050 27,652 77.23
2024-05-24 2024-05-24 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -1,535 325,697 -0.47 38.99 -59,850 12,698,926
2024-05-02 2024-05-01 4 ATR APTARGROUP, INC.
Common Stock
A - Award 1,113 2,007 124.50
2024-04-23 2024-04-23 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -5,504 327,232 -1.65 35.40 -194,836 11,583,686
2024-03-01 2024-03-01 4 CRTO Criteo S.A.
Ordinary Shares
A - Award 39,717 332,736 13.55
2024-02-26 2024-02-26 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -9,653 293,019 -3.19 32.69 -315,557 9,578,791
2024-02-26 2024-02-23 4 CRTO Criteo S.A.
Ordinary Shares
A - Award 52,966 302,672 21.21
2024-01-24 2024-01-23 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -3,622 249,706 -1.43 24.74 -89,608 6,177,726
2023-10-25 2023-10-23 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -2,752 253,328 -1.07 28.16 -77,490 7,133,108
2023-10-25 2023-10-23 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -2,752 253,328 -1.07 28.16 -77,490 7,133,108
2023-10-18 2023-10-17 4 ATR APTARGROUP, INC.
Common Stock
A - Award 894 894
2023-07-26 2023-07-24 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -2,751 258,832 -1.05 32.63 -89,761 8,445,300
2023-07-26 2023-07-24 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -2,710 261,583 -1.03 32.63 -88,423 8,535,061
2023-06-15 2023-06-13 4 TSVT 2seventy bio, Inc.
Common Stock
A - Award 8,400 15,602 116.63
2023-04-26 2023-04-24 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -2,521 264,293 -0.94 30.27 -76,311 8,000,149
2023-04-26 2023-04-24 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -2,521 264,293 -0.94 30.27 -76,311 8,000,149
2023-02-27 2023-02-23 4 CRTO Criteo S.A.
Ordinary Shares
A - Award 24,661 269,335 10.08
2023-02-27 2023-02-23 4 CRTO Criteo S.A.
Ordinary Shares
A - Award 46,600 244,674 23.53
2023-01-24 2023-01-23 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -2,827 198,074 -1.41 28.95 -81,835 5,733,787
2023-01-24 2023-01-23 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -2,827 198,074 -1.41 28.95 -81,835 5,733,787
2022-10-25 2022-10-24 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -28,224 203,728 -12.17 26.05 -735,136 5,306,401
2022-10-25 2022-10-24 4 CRTO Criteo S.A.
Ordinary Shares
S - Sale -25,510 231,952 -9.91 26.05 -664,446 6,041,538
2022-06-09 2022-06-08 4 TSVT 2seventy bio, Inc.
Common Stock
A - Award 4,200 7,202 139.91
2022-02-28 2022-02-24 4 CRTO Criteo S.A.
Ordinary Shares
A - Award 110,327 257,462 74.98
2022-02-28 2022-02-24 4 CRTO Criteo S.A.
Ordinary Shares
A - Award 36,808 147,135 33.36
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -7,500 0 -100.00
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Common Stock
J - Other 0 0
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 4,829 4,829
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Common Stock
A - Award 3,002 3,002
2021-10-01 2021-09-29 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 7,500 7,500
2021-10-01 2021-09-29 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 4,663 4,663
2020-10-27 2020-10-23 4 CRTO Criteo S.A.
Ordinary Shares
A - Award 110,327 110,327
2019-06-11 2019-06-10 4 XPO XPO Logistics, Inc.
Restricted Stock Unit
M - Exercise -2,842 14,208 -16.67
2019-06-11 2019-06-10 4 XPO XPO Logistics, Inc.
Common Stock, par value $0.001 per share
F - Taxes -891 1,951 -31.35 53.78 -47,918 104,925
2019-06-11 2019-06-10 4 XPO XPO Logistics, Inc.
Common Stock, par value $0.001 per share
M - Exercise 2,842 2,842
2019-04-22 2019-04-18 4 XPO XPO Logistics, Inc.
Restricted Stock Unit
A - Award 1,900 1,900
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)